US Cannabis Pharmaceutical Research and Development

US Cannabis Pharmaceutical Research and Development is a privately held U.S. cannabis-sector consulting and development company focused on the legal medical cannabis, hemp, and CBD markets. The company describes itself as a developmental consulting firm that supports clients across education, cultivation, production, dispensing, research and development, compliance, operations, and physician services. Its work appears to center on advisory and market-development services for governments, sovereign entities, and public and private organizations rather than on a disclosed proprietary drug pipeline. Publicly available information indicates it was established in 2014 and has been led by CEO Michael Patterson. The business sits at the intersection of healthcare, cannabis regulation, and international market development.